ADORA2A and Parkinson disease: In a PD animal model treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, caffeine attenuates the degeneration of dopaminergic neurons by inhibiting the adenosine A2A receptor (5).